2. Frampton GM et al. Nat Biotechnol 2013; 31: 1023–1031.
3. FoundationOne®CDx FDA Approval, 2017. Available at: https://www.fda.gov/medical-devices/recently-approved-devices/foundationone-cdx-p170019 (Accessed August 2020).
4. Clark TA et al. J Mol Diagn 2018;20:686–702.
5. Data on file: FoundationOne Liquid CDx Technical Specifications, 2020. Available at: www.eifu.online/FMI/190070862 (Accessed August 2020).
6. Data on file: Clinical and analytical validation data file for FoundationOne Liquid CDx.
7. FoundationOne Liquid CDx FDA Approval, 2020. Available at: https://www.foundationmedicine.com/press-releases/445c1f9e-6cbb-488b-84ad-5f133612b721 (Accessed August 2020).
8. FoundationOne®Heme Technical Specifications, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed August 2020).
9. He J et al. Blood 2016; 127: 3004–3014.
10. Drilon A et al. Clin Cancer Res 2015; 21: 3631–3639.
11. Rankin A et al. Oncologist 2016; 21: 1306–1314.
12. Ross JS et al. Cancer 2016; 122: 2654–2662.
13. Suh JH et al. Oncologist 2016; 21: 684–691.
14. Hirshfield KM et al. Oncologist 2016; 21: 1315–1325.
15. FoundationOne®CDx Sample Report. Available at: https://www.foundationmedicine.nl/content/dam/rfm/sample-reports/f1cdx/eu_version_-_ema_without_page_1/F1CDx%20EU%20Sample%20Report%20(Lung).pdf (Accessed August 2020)
16. Roche Media Release, 2018. Available at: https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed August 2020).